bims-metalz 2022-12-04 papers

Issue of 2022–12–04
two papers selected by
Mikaila Chetty, Goa University

Front Nutr. 2022 ;9 1046726

Nutritional intervention for diabetes mellitus with Alzheimer's disease.

Zhi Li, Simian Li, Ying Xiao, Tian Zhong, Xi Yu, Ling Wang.

The combined disease burden of diabetes mellitus (DM) and Alzheimer's disease (AD) is increasing, and the two diseases share some common pathological changes. However, the pharmacotherapeutic approach to this clinical complexity is limited to symptomatic rather than disease-arresting, with the possible exception of metformin. Whether nutritional intervention might extend or synergize with these effects of metformin is of interest. In particular, dietary patterns with an emphasis on dietary diversity shown to affect cognitive function are of growing interest in a range of food cultural settings. This paper presents the association between diabetes and AD. In addition, the cross-cultural nutritional intervention programs with the potential to mitigate both insulin resistance (IR) and hyperglycemia, together with cognitive impairment are also reviewed. Both dietary patterns and nutritional supplementation showed the effects of improving glycemic control and reducing cognitive decline in diabetes associated with AD, but the intervention specificity remained controversial. Multi-nutrient supplements combined with diverse diets may have preventive and therapeutic potential for DM combined with AD, at least as related to the B vitamin group and folate-dependent homocysteine (Hcy). The nutritional intervention has promise in the prevention and management of DM and AD comorbidities, and more clinical studies would be of nutritional scientific merit.

Keywords: Alzheimer's disease; diabetes mellitus; dietary patterns; nutritional intervention; review

DOI: https://doi.org/10.3389/fnut.2022.1046726

Mech Ageing Dev. 2022 Nov 29. pii: S0047-6374(22)00139-7. [Epub ahead of print] 111757

A Micronutrient Mixture with Collagen Peptides, Probiotics, Cannabidiol, and diet may Reduce Aging, and Development and Progression of Age-Related Alzheimer's Disease, and Improve its Treatment.

Kedar N Prasad.

Human aging involves gradual decline in organ functions leading to organ specific age-related chronic diseases such as Alzheimer's disease (AD). Although advances in the development of new drugs, novel surgical procedures, improved diet and lifestyle, have resulted in doubling of lifespan of humans, the quality of life in many cases remains poor because of increased incidence of age-related chronic diseases. Using experimental models of accelerated aging, several cellular defects associated with aging and AD have been identified. Some cellular defects due to increased oxidative stress, chronic inflammation, autophagy defects, mitochondrial dysfunction, and imbalances in the composition probiotics in favor of harmful bacteria over beneficial bacteria are common to both aging and AD, while others such as telomere attrition, loss of collagen, elastin, and hyaluronic acid, failure of DNA repair system, and impaired immune function are unique to aging; and some such as increased production of beta-amyloids, hyperphosphorylation of tau protein, and abnormal behaviors are unique to AD. It is suggested that supplementation with a micronutrient mixture, probiotics, collagen peptides, CBD, and modifications in the diet and lifestyle may reduce the aging processes, and the development, progression of AD, and improve the treatments of this disease.

Keywords: Aging; Alzheimer’s disease, oxidative stress; cannabidiol (CBD); chronic inflammation; collagen peptides; micronutrients; probiotics

DOI: https://doi.org/10.1016/j.mad.2022.111757